Care doesn’t end when a patient is discharged from a Partners In Health (PIH) facility. In many ways, it marks the beginning. The beginning of a new routine, new responsibilities, and a new type of care.
Such is the case for Nthabiseng Mokone, a 27-year-old patient with multidrug-resistant tuberculosis (MDR-TB). After spending six months in inpatient care, Mokone recently reunited with her loved ones.
Below, follow through photos as Mokone travels from a PIH-supported halfway facility to her home.
Clinical trial results presented for the first time today at the Union World Conference on Lung Health revealed evidence to support the use of four new, improved regimens to treat multi-drug resistant tuberculosis or rifampicin-resistant tuberculosis (MDR/RR-TB). The team—led by Médecins Sans Frontières (MSF), Partners In Health (PIH), and Interactive Research and Development (IRD) and funded by Unitaid—formed the endTB consortium and began this Phase III randomized controlled trial in 2017.
Mobile clinics treat patients sooner, educate families on gender bias and nutrition Posted on Nov 17, 2023 Philistin Gloria’s parents were worried. Their 2-year-old child, the third of four, was refusing to eat, despite her Read more…
Before becoming ill, Kaizer Mahapa, 44, worked as a street vendor in Maseru, Lesotho, selling jewelry, snacks, and fruits at two roadside stalls; one uptown in Maseru and another in his own yard.
Mahapa, who grew up in rural Lesotho, was diagnosed with HIV in 2019. Two years later, he contracted tuberculosis. He’d never attended school, instead cared for the family’s animals. Mahapa was living with his daughter when he fell ill.